Evidence map›Paper›PMID 38243253›Full record

ArticleHarm reduction journal2024

Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years.

Eric Janssen, Mike Vuolo, Stanislas Spilka, Guillaume Airagnes

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Eric JanssenFrench Monitoring Centre for Drugs and Drug Addiction (Observatoire Français des Drogues et des Tendances Addictives - OFDT), 69 rue de Varenne, 75007, Paris, France. eric.janssen@ofdt.fr.ORCID 0000-0002-3820-9657
Mike VuoloDepartment of Sociology, Ohio State University, 238 Townhsend Hall, 1885 Neil Avenue Mall, Columbus, OH, 43210, USA.
Stanislas SpilkaFrench Monitoring Centre for Drugs and Drug Addiction (Observatoire Français des Drogues et des Tendances Addictives - OFDT), 69 rue de Varenne, 75007, Paris, France.
Guillaume AiragnesFrench Monitoring Centre for Drugs and Drug Addiction (Observatoire Français des Drogues et des Tendances Addictives - OFDT), 69 rue de Varenne, 75007, Paris, France.
Inserm · FREuropean Monitoring Centre for Drugs and Drug Addiction · PTThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsistent reports from health professionals suggest that heroin is commonly used by patients undergoing opioid maintenance treatment (OMT) in France, potentially jeopardizing their recovery process. However, there has been no formal epidemiological assessment on the matter.

methodsWe use a yearly updated compendium retrieving information on patients admitted in treatment centres in France between 2010 and 2020. Given the hierarchical nature of the data collection, we conduct 2-level modified Poisson regressions to estimate the risks of past month heroin use among patients on OMT.

resultsDespite an overall decreasing trend over time, heroin use among patients on OMT is indeed common, with half of patients declaring concurrent use. Our study unveils differentiated risks of heroin use vary according to the type of OMT, with patients on methadone more likely to use heroin compared to those on buprenorphine. The use of multilevel-related measures also uncovers high heterogeneity among patients' profiles, reflecting different stages in the treatment process, as well as differentiated practices across treatment centres.

conclusionOpioid maintenance treatment is associated with heroin use, in particular when methadone is involved. The heterogeneity among patients on OMT should be given particular attention, as it underscores the need for tailored interventions.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidHeroinHumansMethadoneOpiate Substitution TreatmentAnalgesics, OpioidBuprenorphineHeroinMethadoneFranceHeroinHeterogeneityMultilevel analysisOpioid maintenance treatment

Identifiers

PMID38243253
PMCPMC10799399
OpenAlexW4391035502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.